Carthera
PrivateLast Round
Series B
Extension
Dec 11, 2023
Total Funding Raised
$102.54M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Carthera operates in Healthcare & Life Sciences and is based in Lyon. Its latest recorded funding round was a Series B Extension round in December 2023.
Carthera is a medtech company that develops ultrasound-based medical devices designed to treat brain disorders through intracranial implants and microbubble agents that enhance drug delivery to the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carthera Comparables
Compare Carthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OxSonics Therapeutics | 79% | |
| TheraSonic | 78% | |
| NaviFUS Corp. | 77% |
For institutional investors. Book with your work email.
Carthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 11, 2023 | ||||
| Series B | Jun 27, 2023 | ||||
| Grant | Sep 14, 2020 | ||||
| Series B | Dec 12, 2018 | ||||
| Grant | Oct 1, 2016 | ||||
Series A | Jul 8, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Carthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant, Series B |
| Unorthodox Ventures | Series B, Series B Extension |
| Supernova Invest | Series B, Seed, Series B Extension |
| Panakès Partners | Series B, Series A |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 226% MoM, reaching 2.9K.
- Jun 27, 2023
$40M round led by European Innovation Council and Relyens.
For institutional investors. Book with your work email.
Carthera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Carthera's valuation, stock price, and market status.
Is Carthera a public or private company?
Carthera is a private company.
What is the current stock price of Carthera?
Carthera is a private company, so its shares have no public market price. Caplight tracks Carthera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Carthera worth (valuation)?
Valuation information for Carthera is not publicly available.
Can I buy Carthera stock?
Carthera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Carthera's last funding round?
Carthera's most recent funding round was Series B Extension on December 11, 2023.
Who are the main investors in Carthera?
Key investors in Carthera include European Innovation Council Fund, Unorthodox Ventures, Panakès Partners.
Will Carthera IPO soon?
No public IPO plans have been announced for Carthera.
How can I track Carthera secondary market activity?
Caplight tracks bids, offers, and trades in Carthera's shares on secondary markets.